Showing 981-990 of 1346 results for "".
Analyzing the New Consensus Statement on Immunotherapy for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-the-new-consensus-statement-on-immunotherapy-for-melanoma/21506/Integrating Public Relations and SEO to Promote Your Practice
https://practicaldermatology.com/topics/practice-management/integrating-public-relations-and-seo-to-promote-your-practice/21524/Dermatologists can reap the benefits of creating an integrated online marketing campaign that combines the strengths of PR and SEO.Patient Outreach: Lost to Follow-up Doesn't Have to Mean Lost
https://practicaldermatology.com/topics/practice-management/patient-outreach-lost-to-follow-up-doesnt-have-to-mean-lost/21531/Effective patient outreach improves outcomes, saves lives, and increases practice revenue.PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.Currents
https://practicaldermatology.com/topics/skin-cancer-photoprotection/currents/22968/Targeting MelanomaRe-Considering the Psychological Components of Psoriasis
https://practicaldermatology.com/topics/psoriasis/re-considering-the-psychological-components-of-psoriasis/22962/With convincing data that show that psoriasis directly inhibits patients' daily activities and quality of life, clinicians must emphasize trust and empathy.Integrating Excimer Laser Therapy for Psoriasis and Vitiligo
https://practicaldermatology.com/topics/psoriasis/integrating-excimer-laser-therapy-for-psoriasis-and-vitiligo/22959/New patient and practice support programs may expand interest in laser therapy for common medical conditions.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/22916/Physician Programs: Opening new Patient Gateways
https://practicaldermatology.com/topics/practice-management/physician-programs-opening-new-patient-gateways/22914/Physician programs support dermatologists' practice building and provide a gateway for additional services.